Comparative study of centesimal and millesimal potency in treatment of allergic rhinitis

A Comparative Study on Homoeopathic Scale of Centesimal Potency and Millesimal Potency in the Treatment of Allergic Rhinitis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042495

Enrollment

Registered

2022-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic medicines: Homoeopathic medicines are selected on basis of symptom similarity and individualisation by using homoeopathic scale of millesimal and centesimal potency and th

Eligibility

Inclusion criteria

Inclusion criteria: patients selected from age 10 to 60 and patients with clinical presentation of allergic rhinitis

Exclusion criteria

Exclusion criteria: cases with complications of allergic rhinitis and patients suffering from other systemic diseases and pregnant ladies will not be considered for the studies

Design outcomes

Primary

Measure	Time frame
Absolute Eosinophil Count Serum IgE levelTimepoint: after 6 months	—

Secondary

Measure	Time frame
it is expected that the proposed study will be useful in reducing the symptoms of Allergic Rhinitis and to improve the quality of life of the patientsTimepoint: after 6 months	—

Countries

India

Contacts

Public ContactDr E Nisha Paul

Vinayaka Missions homoeopathic medical college and Hospital

Nisha.gopal2012@gmail.com9995680275

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026